Pulsed intravenous cyclophosphamide for sle retinal vasculitis.

Retin Cases Brief Rep

From the Departments of *Ophthalmology and †Rheumatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia; and ‡Department of Medicine, University of Adelaide, Adelaide, South Australia, Australia.

Published: November 2014

Purpose: To report a case of systemic lupus erythematosus vaso-occlusive retinopathy with severe visual loss treated with intravenous pulsed cyclophosphamide.

Methods: Retrospective interventional case report.

Results: A 20-year-old Cambodian woman with newly diagnosed systemic lupus erythematosus presented with acute visual loss. Fluorescein fundus angiography demonstrated occlusive retinal vasculitis. Treatment with pulsed intravenous cyclophosphamide, intravenous methylprednisolone, and anticoagulation resulted in recovery of vision from count fingers to 6/6 in both eyes.

Conclusion: Early aggressive immunosuppression and anticoagulation for systemic lupus erythematosus retinal vasculitis can be beneficial in preventing disease progression and restoring vision. Further studies are needed to compare dosage regimens.

Download full-text PDF

Source
http://dx.doi.org/10.1097/ICB.0b013e3182160776DOI Listing

Publication Analysis

Top Keywords

retinal vasculitis
12
systemic lupus
12
lupus erythematosus
12
pulsed intravenous
8
intravenous cyclophosphamide
8
visual loss
8
cyclophosphamide sle
4
sle retinal
4
vasculitis purpose
4
purpose report
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!